Eritoran Tetrasodium T27281
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Eritoran Tetrasodium, a TLR4 receptor antagonist, is used potentially for the treatment of type 2 diabetes.
CAS nr:
185954-98-7
Purity:
98%
Molecular Weight:
1401,6
SMILES:
O=P([O-])([O-])O[C@H]1O[C@H](CO[C@@H]2O[C@H](COC)[C@@H](OP([O-])([O-])=O)[C@H](OCC[C@H](OC)CCCCCCC)[C@H]2NC(CCCCCCCCC/C=C\CCCCCC)=O)[C@@H](O)[C@H](OCCCCCCCCCC)[C@H]1NC(CC(CCCCCCCCCCC)=O)=O.[Na+].[Na+].[Na+].[Na+]
Formula:
C66H122N2Na4O19P2
Pathway:
Target:
